Sartorius and MAbSilico are collaborating to connect Al-driven protein discovery with automated, high-throughput cell line ...

Singapore imaging provider is the earliest site in the region to adopt a new generation of MRI technology. MR31 will enable ...

Suvoda, a global clinical trial technology company, announced a new release of important advancements since unifying the ...

First-in-human study evaluates dual-target, dual-payload ADC in advanced ovarian cancer and other solid tumours Phrontline ...

Rznomics Inc., a biopharmaceutical company specializing in the development of RNA-based gene therapies, announced that the ...

In TRIUMPH-2, participants with obesity and type 2 diabetes taking retatrutide 12 mg lost an average of 49.6 lbs (20.8%) over ...

Researchers will gain an integrated synthetic data foundation and an advanced custom search platform to support reaction data ...

Piramal Pharma Solutions is investing over $5.3 million in its Aurora drug substance facility to upgrade site infrastructure.

Hengrui Pharma announced that it has entered into a license agreement with Novo Nordisk (Novo) for HRS-1596, a phase I-ready ...

Discontinuations by stated reason and by phase, APAC sponsors, 1 January to 30 September 2026. Source: BioPharma APAC ...

Link Cell Therapies ("Link"), an oncology cell therapy company utilizing its proprietary logic-gating technology to develop ...

NouvSight001 secures regulatory clearances from the US FDA and China’s NMPA for clinical development in retinitis pigmentosa, ...